Three growth stocks are emerging as potential bargain buys this month: Novo Nordisk (NVO), PDD Holdings (PDD), and Intuit (INTU). Each has faced significant challenges recently, with Novo Nordisk down 36% over the past year due to rising competition in the GLP-1 market. Despite a change in leadership and projected revenue declines, its strong fundamentals and a low forward P/E of 13 suggest it may be undervalued.
PDD Holdings, known for its Temu marketplace, has also seen a 12% drop in stock price amid trade uncertainties. However, it reported 12% revenue growth in its latest quarter and trades at a forward P/E of just eight, presenting a compelling opportunity for long-term investors willing to weather current headwinds.
Intuit, down 36% as well, has been impacted by AI concerns, yet it continues to show solid growth with a 17% revenue increase in its latest quarter. Trading at a forward P/E of 15, Intuit offers significant upside potential for patient investors, leveraging its trusted software brands to navigate the evolving tech landscape.
Source: fool.com